Over 4% of the world’s population suffers from one or more of the over 80 autoimmune diseases identified to date. A large variety of treatment approaches have already been developed to curb the detrimental effects of autoimmune diseases, bringing new hope to patients and their families. 

With this event, Inova seeks to facilitate the bridge between science and business. Together with BIO, they are organising this Immunology Virtual Partnering Event. Through online one-to-one meetings taking place 9-12 March, researchers, biotechs and biopharmaceutical companies will discuss the latest research from immunology congresses, pitch ideas and partner to prioritise the most promising research efforts.

This event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise, leading digital networking platform and years of experience organising partnering events to connect scientific and business communities for the benefit of patients worldwide.